Investigating the Pharmacokinetics and Pharmacodynamics of Recombinant Human Insulin Administered by Dry Powder Inhaler

Clinical trial NCT00426920 · UNKNOWN

Trial details

NCT number: NCT00426920
Sponsor: QDose Limited
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus

Start date: 2007-02-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.